1131871-23-2Relevant academic research and scientific papers
COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
-
Page/Page column 31, (2010/10/03)
The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes (I).
COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
-
Page/Page column 39-40, (2009/04/25)
The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes.
